Pfizer CEO Albert Bourla Talks Post-Covid Transition

Pfizer's sales missed estimates for the quarter as the drugmaker tries to transition out of the pandemic. Pfizer chairman and CEO Albert Bourla discusses the path ahead for the company, including its plans for acquisitions. He speaks with Bloomberg Wall Street Week host David Westin. See omnystudio.com/listener for privacy information.